We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
AUM
$859M
AUM Growth
-$429M
Cap. Flow
-$442M
Cap. Flow %
-51.43%
Top 10 Hldgs %
4.21%
Holding
1,520
New
386
Increased
181
Reduced
340
Closed
602

Top Buys

Rank Stock Value
1
GOSS icon
Gossamer Bio
GOSS
+$5.95M
2
MRVL icon
Marvell Technology
MRVL
+$4M
3
AAPL icon
Apple
AAPL
+$3.97M
4
DIS icon
Walt Disney
DIS
+$3.95M
5
ROL icon
Rollins
ROL
+$3.82M

Top Sells

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$7.11M
2
ICE icon
Intercontinental Exchange
ICE
+$6.91M
3
XRAY icon
Dentsply Sirona
XRAY
+$6.81M
4
CSCO icon
Cisco
CSCO
+$6.77M
5
QRVO icon
Qorvo
QRVO
+$6.72M

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Consumer Discretionary 16.59%
3 Industrials 13.62%
4 Financials 13.07%
5 Healthcare 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRMD icon
1376
TORM
TRMD
$3.09B
-40,480
Closed -$821K
TRMK icon
1377
Trustmark
TRMK
$2.8B
-15,865
Closed -$486K
TROW icon
1378
T. Rowe Price
TROW
$24.2B
-27,055
Closed -$2.84M
TRS icon
1379
TriMas Corp
TRS
$1.45B
-8,932
Closed -$224K
TRUP icon
1380
Trupanion
TRUP
$1.09B
-25,260
Closed -$1.5M
TSHA icon
1381
Taysha Gene Therapies
TSHA
$1.66B
-14,679
Closed -$28K
TTMI icon
1382
TTM Technologies
TTMI
$12.6B
-71,082
Closed -$937K
TTSH
1383
DELISTED
Tile Shop Holdings
TTSH
-20,554
Closed -$72K
TVTX icon
1384
Travere Therapeutics
TVTX
$5.11B
-36,821
Closed -$907K
TWI icon
1385
Titan International
TWI
$466M
-53,005
Closed -$643K
TW icon
1386
Tradeweb Markets
TW
$21.5B
-53,173
Closed -$3M
TWST icon
1387
Twist Bioscience
TWST
$6.29B
-22,407
Closed -$790K
TXG icon
1388
10x Genomics
TXG
$5.97B
-31,774
Closed -$905K
U icon
1389
Unity
U
$14.6B
-95,709
Closed -$3.05M
UA icon
1390
Under Armour Class C
UA
$2.83B
-656,656
Closed -$3.91M
UAA icon
1391
Under Armour
UAA
$2.89B
-826,790
Closed -$5.5M
UBER icon
1392
Uber
UBER
$146B
-63,053
Closed -$1.67M
UCTT
1393
Ultra Clean Holdings
UCTT
$4B
-34,819
Closed -$897K
UHS icon
1394
Universal Health Services
UHS
$10.2B
-43,559
Closed -$3.84M
UPST icon
1395
Upstart Holdings
UPST
$2.82B
-95,469
Closed -$1.99M
USFD icon
1396
US Foods
USFD
$21.9B
-45,266
Closed -$1.2M
VBTX
1397
DELISTED
Veritex Holdings
VBTX
-52,185
Closed -$1.39M
VERV
1398
DELISTED
Verve Therapeutics
VERV
-27,476
Closed -$944K
VERU icon
1399
Veru
VERU
$36.3M
-19,191
Closed -$2.21M
VHC icon
1400
VirnetX Holding Corp
VHC
$56.8M
-1,088
Closed -$25K

Similar funds

Occudo Quantitative Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Occudo Quantitative Strategies held 1,520 positions worth $859M, down 33% from $1.29B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Occudo Quantitative Strategies withdrew a net $442M in Q4 2022, closing 602 positions and reducing 340 holdings. Its most notable exit was Datadog, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Occudo Quantitative Strategies opened a new position in Marvell Technology worth $3.63M.

  • Occudo Quantitative Strategies's largest Q4 2022 buy was Marvell Technology: 97,934 shares worth $3.63M.
  • Occudo Quantitative Strategies added most to Gossamer Bio in Q4 2022, an estimated $5.95M increase.
  • Occudo Quantitative Strategies's biggest Q4 2022 reduction was Align Technology, cutting an estimated $6.27M.
  • Occudo Quantitative Strategies fully exited Datadog in Q4 2022, selling an estimated $7.11M.
  • Occudo Quantitative Strategies's ten largest holdings make up 4.2% of its $859M portfolio in Q4 2022.
  • Occudo Quantitative Strategies opened 386 new positions and closed 602 in Q4 2022.
  • Occudo Quantitative Strategies's portfolio value fell 33% quarter-over-quarter to $859M.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.